Overall, these data show that in the interaction between HCC cancer cells and TAM, the expression of FABPs, particularly FABP5, and the exchange of lipid metabolites like long-chain unsaturated FAs, reprogram TAMs via the FABP/PPAR pathway. This evidence concerns the gene FABP5 and hepatocellular carcinoma.